

Use of IO therapies – including immune checkpoint inhibitors – in clinical care and clinical trials for solid tumors was the topic of an advisory board meeting held in Mumbai, India on February 8, 2020, by the IQVIA medical and clinical team with Key Opinion Leaders from various regions of India. The White Paper covers the salient topics discussed.